Clinical Trials Directory

Trials / Completed

CompletedNCT01982526

Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
17 Years – 42 Years
Healthy volunteers
Accepted

Summary

Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.

Detailed description

long term results of the postoperative follow up for the endometrioma patients

Conditions

Timeline

Start date
2012-05-01
Primary completion
2013-05-01
Completion
2016-05-01
First posted
2013-11-13
Last updated
2018-08-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01982526. Inclusion in this directory is not an endorsement.

Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients (NCT01982526) · Clinical Trials Directory